About Alliance Pharma plc (LON:APH)
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.
Industry, Sector and Symbol
Industry Generic Pharmaceuticals
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Trailing EPSGBX 0.05
Return on Equity14.63%
Return on Assets8.39%
Frequently Asked Questions for Alliance Pharma plc (LON:APH)
What is Alliance Pharma plc's stock symbol?
Alliance Pharma plc trades on the London Stock Exchange (LON) under the ticker symbol "APH."
How often does Alliance Pharma plc pay dividends? What is the dividend yield for Alliance Pharma plc?
Alliance Pharma plc declared a dividend on Wednesday, September 13th. Stockholders of record on Thursday, December 21st will be paid a dividend of GBX 0.44 per share on Thursday, January 11th. This represents a dividend yield of 0.84%. The ex-dividend date is Thursday, December 21st. The official announcement can be viewed at this link. View Alliance Pharma plc's Dividend History.
Where is Alliance Pharma plc's stock going? Where will Alliance Pharma plc's stock price be in 2017?
3 brokerages have issued 12-month price objectives for Alliance Pharma plc's stock. Their forecasts range from GBX 58 to GBX 60. On average, they anticipate Alliance Pharma plc's share price to reach GBX 59 in the next year. View Analyst Ratings for Alliance Pharma plc.
Who are some of Alliance Pharma plc's key competitors?
Some companies that are related to Alliance Pharma plc include Oxford Instruments plc (OXIG), Gamma Communications PLC (GAMA), Accesso Technology Group PLC (ACSO), AO World plc (AO), Raven Russia Limited (RUS), Consort Medical plc (CSRT), Empiric Student Property (ESP), Watkin Jones PLC (WJG), Chesnara plc (CSN), Sound Energy plc (SOU), Hurricane Energy PLC (HUR), KCOM Group PLC (KCOM), CMC Markets Plc (CMCX), 4imprint Group plc (FOUR), Stock Spirits Group PLC (STCK), On the Beach Group plc (OTB), Touchstone Innovations PLC (IVO) and Highland Gold Mining Limited (HGM).
Who are Alliance Pharma plc's key executives?
Alliance Pharma plc's management team includes the folowing people:
- John Dawson, Chief Executive Officer, Executive Director
- Andrew Franklin, Finance Director, Director
- Peter Butterfield, Chief Commercial Officer, Executive Director
- Janice Timberlake, Director of Human Resources
- Margaret Boulton, Medical and Regulatory Affairs Director
- Stephen Kidner, Operations Director
- Dan Thomas, Business Development Director
- Sarah Robinson, Company Secretary
- Andrew L. Smith, Non-Executive Chairman of the Board (Age 58)
- Thomas Theodore Casdagli, Non-Executive Director
How do I buy Alliance Pharma plc stock?
Shares of Alliance Pharma plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Alliance Pharma plc's stock price today?
One share of Alliance Pharma plc stock can currently be purchased for approximately GBX 59.36.
How big of a company is Alliance Pharma plc?
Alliance Pharma plc has a market capitalization of £283.65 million.
How can I contact Alliance Pharma plc?
Alliance Pharma plc's mailing address is Avonbridge House, Bath Road, CHIPPENHAM, SN15 2BB, United Kingdom. The company can be reached via phone at +44-1249-466966.
MarketBeat Community Rating for Alliance Pharma plc (APH)MarketBeat's community ratings are surveys of what our community members think about Alliance Pharma plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Alliance Pharma plc (LON:APH) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 3 Buy Ratings, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||GBX 59|
Consensus Price Target History for Alliance Pharma plc (LON:APH)
Analysts' Ratings History for Alliance Pharma plc (LON:APH)
(Data available from 11/24/2015 forward)
|11/21/2017||FinnCap||Reiterated Rating||Buy||GBX 58|
|9/13/2017||N+1 Singer||Reiterated Rating||not rated|
|9/13/2017||Investec||Initiated Coverage||Buy||GBX 59|
|9/13/2017||Numis Securities Ltd||Reiterated Rating||Buy||GBX 60|
Earnings History for Alliance Pharma plc (LON:APH)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Alliance Pharma plc (LON:APH)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for Alliance Pharma plc (LON APH)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Alliance Pharma plc (LON APH)
Insider Trades by Quarter for Alliance Pharma plc (LON APH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|2/14/2017||Peter Butterfield||Insider||Sell||61,846||GBX 49||£30,304.54|
|9/22/2016||John Dawson||Insider||Sell||3,000,000||GBX 45||£1,350,000|
|12/17/2015||Smith,Andrew L||Insider||Buy||75,000||GBX 41||£30,750|
|6/16/2015||Nigel Clifford||Insider||Buy||58,227||GBX 39.50||£22,999.67|
Latest Headlines for Alliance Pharma plc (LON APH)
Financials are not available for this stock.
Alliance Pharma plc (LON APH) Chart for Friday, November, 24, 2017